HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takashi Furusawa Selected Research

Takashi Furusawa Research Topics

Disease

4Neoplasms (Cancer)
02/2024 - 08/2005
2Carcinogenesis
01/2017 - 01/2014
2Hypersensitivity (Allergy)
08/2005 - 04/2003
1Lung Neoplasms (Lung Cancer)
02/2024
1Body Weight (Weight, Body)
11/2022
1Leukemia
01/2020
1Trisomy (Trisomies)
11/2018
1Down Syndrome Critical Region
11/2018
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
11/2018
1Type 2 Diabetes Mellitus (MODY)
10/2009
1Ataxia Telangiectasia (Louis Bar Syndrome)
01/2009
1Genomic Instability
01/2009
1Blister (Bulla)
02/2006
1Neoplasm Metastasis (Metastasis)
08/2005

Drug/Important Bio-Agent (IBA)

7HMGN1 Protein (HMGN1)IBA
11/2022 - 04/2003
6Nucleosomes (Nucleosome)IBA
11/2022 - 04/2003
5Carrier Proteins (Binding Protein)IBA
11/2022 - 08/2005
5ChromatinIBA
01/2020 - 04/2003
2DNA (Deoxyribonucleic Acid)IBA
01/2020 - 01/2009
1olaparibIBA
02/2024
1Monocarboxylic Acid TransportersIBA
02/2024
1Poly(ADP-ribose) Polymerase InhibitorsIBA
02/2024
1HMGN2 Protein (HMGN2)IBA
11/2022
1Histones (Histone)IBA
01/2020
1Oncogene Proteins (Oncogene Protein)IBA
01/2020
1Diethylnitrosamine (N-Nitrosodiethylamine)IBA
01/2014
1Glucose (Dextrose)FDA LinkGeneric
10/2009
11,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
01/2009
1Protein Kinases (Protein Kinase)IBA
01/2009
1AgarIBA
08/2005
1HMGN Proteins (HMGN)IBA
08/2005
1Proteins (Proteins, Gene)FDA Link
08/2005

Therapy/Procedure

1Drug Therapy (Chemotherapy)
02/2024